Similar Articles
2181 Endoscopic treatment of esophageal varices in patients with liver cirrhosis
2182 Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma
2183 Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection
2184 Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma
2185 Metabolic syndrome in hypertensive patients: An unholy alliance
2186 Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome
2187 Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease
2188 Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
2189 Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma
2190 Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA